A Global Gateway for Oncology Drug Development
ClinOx offers clients knowledge and expertise in the development, placement,
conduct and analysis of early phase oncology clinical trials, with particular
emphasis on pharmacokinetic and mechanistic endpoints.
ClinOx is a new company based in Oxford and working with national and
international research networks, and centres of scientific excellence with
clinical expertise, to provide an extraordinary opportunity for both
pharmaceutical companies and biotechnology firms to:
-
fast-track novel anti-cancer, therapeutic and diagnostic strategies;
-
test their promise in mechanistic clinical trials; and
-
enable them to make critical decisions on their drug portfolio at an early
stage
ClinOx is uniquely positioned to respond to the challenges posed by the new era
of molecular targeted therapies, including the identification of patient
subsets based on the biological or genetic expression of their tumour.
...Translating science into medicines...
